[Federal Register Volume 61, Number 121 (Friday, June 21, 1996)]
[Notices]
[Pages 31944-31945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-15819]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 DAY-14]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request more information on these
projects or to obtain a copy of the data collection plans and
instruments, call the CDC Reports Clearance Officer at (404) 639-7090.
Send written comments to Wilma Johnson, CDC Reports Clearance Officer,
1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should
be received within 30 days of this notice.
The following requests have been submitted for review since the
last publication date on May 29, 1996.
Proposed Projects
1. Importation and Shipment of Etiologic Agents--(0920-0199)--
Revision--The Antiterrorism and Effective Death Penalty Act of 1996
(Public Law 104-132) authorizes the Secretary of Health and Human
Services (HHS) to regulate the transfer of certain infectious agents
harmful to humans. The Centers for Disease Control and Prevention (CDC)
is the agency within the Department responsible for promulgating
regulations. CDC is proposing a rule designed to ensure that select
infectious agents are not shipped to parties not equipped to handle
them appropriately, or who do not have legitimate reasons to use them
and to implement a system whereby scientists and researchers involved
in legitimate research may continue transferring and receiving these
agents without undue burdens. Respondents include laboratory facilities
such as those operated by government agencies, universities, research
institutions, and commercial entities.
Those facilities requesting select infectious agents listed in the
regulation must register with the Secretary of HHS, or with registering
entities authorized by the Secretary, as capable and equipped to handle
the select infectious agents in accordance with guidelines developed by
CDC, the National Institutes for Health (NIH) and the Department of
Defense.
Once registered, facilities must complete a federally-developed
form, CDC Form EA-101, for each transfer of the agent. Information on
this form will include the name of the requestor and requesting
facility, the name of the transferor and transferring facility, the
name of the responsible facility official for the transferor and
requestor, the requesting facility's registration number, the
transferring facility's registration number, the name of the agent(s)
being shipped, and the proposed use of the agent. The package is being
revised to include burden for laboratories to register with the
Secretary.
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
CFR section Number of responses/ response (in
respondents respondents hrs.)
----------------------------------------------------------------------------------------------------------------
Application for Permit.......................................... 1,000 1 20/60
72.6(a)......................................................... 1,000 1 15/60
72.6(d)......................................................... 1,000 3 1.05
72.6(e)......................................................... 120 21 10/60
72.6(f)......................................................... 1,000 3 6/60
----------------------------------------------------------------------------------------------------------------
The total annual burden is 4,453. Send comments to Desk officer,
CDC; Human Resources and Housing Branch, New Executive Office Building,
Room 10235; Washington, DC 20503.
2. Tuberculosis in Children--New--The Centers for Disease Control
and Prevention, National Center for HIV, STD, and TB Prevention,
Division of Tuberculosis Elimination, Surveillance Epidemiologic
Investigations Branch will be conducting a study for the purpose of
performing research concerning the epidemiology of TB in children,
including children co-infected with the human immunodeficiency virus
(HIV). The study will involve the following modules: (1) The
epidemiology, magnitude and risk factors for TB in children, including
HIV-infected children; (2) studies of the diagnosis of TB in children,
and (3) reducing the risk of nosocomial transmission of TB in pediatric
settings.
[[Page 31945]]
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Respondents No. of Responses/ response (in
respondents respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Positive Tuberculin Skin Testing Form........................... 100 1 0.33
Negative Tuberculin Skin Testing Form........................... 200 1 0.33
Parental Questionnaire.......................................... 150 1 0.33
----------------------------------------------------------------------------------------------------------------
The total annual burden is 150. Send comments to Desk officer, CDC;
Human Resources and Housing Branch, New Executive Office Building, Room
10235; Washington, DC 20503.
3. HIV Prevention Programs in National/Regional Minority and Other
Community Based Organization Project Reports--(0920-0249)--
Reinstatement--CDC is responsible for monitoring and evaluating HIV
prevention activities conducted under cooperative agreements with
National/Regional Minority and Other Community Based Organizations.
Enhancing and assuring quality programming requires that CDC have
current information regarding the progress of activities and services
supported through these cooperative agreements. In some instances,
these cooperative agreements have been awarded to organizations that
have not previously been awarded Federal funds, or provided HIV
prevention services. Additionally, many have limited infrastructure,
requiring greater oversight and technical assistance. Technical
assistance site visits and telephone communications do provide some of
the required information; yet, site visits have been dramatically
reduced and specific contents of phone conversations can be easily
forgotten, especially when several awards are administered by one
individual. Therefore, thorough quarterly project reports are
considered a critical component of the monitoring/evaluation process.
Because this program encompasses at least 23 N/RMOs and 90 CBOs awards,
there is a need for a standardized system for reporting the progress of
each organization's activities.
----------------------------------------------------------------------------------------------------------------
No. Of Avg. Burden/
Respondents No. Of Responses/ Response (in
Respondents Respondent hrs.)
----------------------------------------------------------------------------------------------------------------
National/Regional............................................... 23 4 4
CBO............................................................. 90 4 4
----------------------------------------------------------------------------------------------------------------
The total annual burden is 1808. Send comments to Desk officer,
CDC; Human Resources and Housing Branch, New Executive Office Building,
Room 10235; Washington, DC 20503.
Dated: June 17, 1996.
Wilma G. Johnson,
Acting Associate Director for Policy Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 96-15819 Filed 6-20-96; 8:45 am]
BILLING CODE 4163-18-P
